{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "Parkinson disease", "beta-amyloid", "glutamate excitotoxicity", "neurodegenerative diseases (NDS).", "plant derived-compounds"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33845746", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "25"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "05"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1570159X19666210412095251"], "Journal": {"ISSN": "1875-6190", "JournalIssue": {"Volume": "19", "Issue": "9", "PubDate": {"Year": "2021"}}, "Title": "Current neuropharmacology", "ISOAbbreviation": "Curr Neuropharmacol"}, "ArticleTitle": "Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-\u03b2-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells.", "Pagination": {"StartPage": "1416", "EndPage": "1441", "MedlinePgn": "1416-1441"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) and Parkinson's disease (PD) are notorious neurodegenerative diseases amongst the general population. Being age-associated diseases, the prevalence of AD and PD is forecasted to rapidly escalate with the progressive aging population of the world. These diseases are complex and multifactorial. Among different events, amyloid \u03b2 peptide (A\u03b2) induced toxicity is a well-established pathway of neuronal cell death, which plays a vital function in AD. Glutamate, the major excitatory transmitter, acts as a neurotoxin when present in excess at the synapses; this latter mechanism is termed excitotoxicity. It is hypothesised that glutamate-induced excitotoxicity contributes to the pathogenesis of AD and PD. No cure for AD and PD is currently available and the currently approved drugs available to treat these diseases have limited effectiveness and pose adverse effects. Indeed, plants have been a major source for the discovery of novel pharmacologically active compounds for distinct pathological conditions. Diverse plant species employed for brain-related disorders in traditional medicine are being explored to determine the scientific rationale behind their uses. Herein, we present a comprehensive review of plants and their constituents that have shown promise in reversing the (i) amyloid-\u03b2 -related toxicity in AD models and (ii) glutamate-induced excitotoxicity in AD and PD models. This review summarizes information regarding the phytochemistry, biological and cellular activities, and clinical trials of several plant species in view to provide adequate scientific baseline information that could be used in the drug development process, thereby providing effective leads for AD and PD."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Reduit, Mauritius."}], "LastName": "Lobine", "ForeName": "Devina", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Reduit, Mauritius."}], "LastName": "Sadeer", "ForeName": "Nabeelah", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Reduit, Mauritius."}], "LastName": "Jugreet", "ForeName": "Sharmeen", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Reduit, Mauritius."}], "LastName": "Suroowan", "ForeName": "Shanoo", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Faculty of Medicine and Health Sciences, University of Mauritius, Reduit, Mauritius."}], "LastName": "Keenoo", "ForeName": "Bibi Sumera", "Initials": "BS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Allied Health Sciences, University Institute of Diet and Nutritional Sciences, The University of Lahore, Pakistan."}], "LastName": "Imran", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia."}], "LastName": "Venugopala", "ForeName": "Katharigatta N", "Initials": "KN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Aromatic Plants Research Dept., National Research Center, 33 El Bohouth St., Dokki, Giza, P.O.12622, Egypt."}], "LastName": "Ibrahim", "ForeName": "Faten Mohamed", "Initials": "FM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physiology and Biochemistry Research Laboratory, Department of Biology, Science Faculty, Selcuk University, Konya, Turkey."}], "LastName": "Zengin", "ForeName": "Gokhan", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Reduit, Mauritius."}], "LastName": "Mahomoodally", "ForeName": "Mohamad Fawzi", "Initials": "MF"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Neuropharmacol", "NlmUniqueID": "101157239", "ISSNLinking": "1570-159X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "3KX376GY7L", "NameOfSubstance": "Glutamic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["toxicity"], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": ["toxicity"], "DescriptorName": "Glutamic Acid"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Parkinson Disease"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Di Paolo M., Papi L., Gori F., Turillazzi E. Natural products in neurodegenerative diseases: A great promise but an ethical challenge. Int. J. Mol. Sci. 2019;20(20)", "ArticleIdList": ["PMC6834164", "31635296"]}, {"Citation": "Dementia W.H.O. https://www.who.int/news-room/fact-sheets/detail/dementia"}, {"Citation": "https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet"}, {"Citation": "Gupta V., Sharma B. Role of phytochemicals in neurotrophins mediated regulation of Alzheimer\u2019s Disease. IJCAM. 2017;7:1\u20137."}, {"Citation": "Gitler A.D., Dhillon P., Shorter J. Neurodegenerative disease: models, mechanisms, and a new hope. DMM. 2017;10(5):499\u2013502.", "ArticleIdList": ["PMC5451177", "28468935"]}, {"Citation": "Zolezzi J.M., Bast\u00edas-Candia S., Inestrosa N.C. In: Recent Advances in Neurodegeneration. Borreca A., editor. London, UK: IntechOpen; 2018. Molecular basis of neurodegeneration: Lessons from Alzheimer\u2019s and Parkinson\u2019s diseases."}, {"Citation": "Heemels M.T. Neurodegenerative diseases. Nature. 2016;539(7628):179.", "ArticleIdList": ["27830810"]}, {"Citation": "Apostolova L.G. Alzheimer disease. Continuum (N. Y.) 2016;22(2):419.", "ArticleIdList": ["PMC5390933", "27042902"]}, {"Citation": "Khushboo S.B., Sharma B. Antidepressants: mechanism of action, toxicity and possible amelioration. J Appl Biotechnol Bioeng. 2017;3:1\u201313."}, {"Citation": "Walter B.L., Vitek J.L. 2006."}, {"Citation": "Jellinger K.A. In: Pathobiology of Human Disease. McManus L.M., Mitchell R.N., editors. San Diego, US: Academic Press; 2014. Parkinson\u2019s disease. pp. 2021\u20132035."}, {"Citation": "Moran M. 2007."}, {"Citation": "Xie A., Gao J., Xu L., Meng D. Shared mechanisms of neurodegeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease. BioMed Res. Int. 2014;2014:648740.", "ArticleIdList": ["PMC4037122", "24900975"]}, {"Citation": "Sharma B., Gupta V. Modulations of mammalian brain functions by antidepressant drugs: role of some phytochemicals as prospective antidepressants. Evid Based Med Pract. 2016;2:1\u201312."}, {"Citation": "Salat D., Tolosa E. Levodopa in the treatment of Parkinson\u2019s disease: current status and new developments. J. Parkinsons Dis. 2013;3(3):255\u2013269.", "ArticleIdList": ["23948989"]}, {"Citation": "Yadav A.P., Fuentes R., Zhang H., Vinholo T., Wang C.H., Freire M.A., Nicolelis M.A. Chronic spinal cord electrical stimulation protects against 6-hydroxydopamine lesions. Sci. Rep. 2014;4:3839.", "ArticleIdList": ["PMC3899601", "24452435"]}, {"Citation": "Stanzione P., Tropepi D. Drugs and clinical trials in neurodegenerative diseases. Ann. Ist. Super. Sanita. 2011;47:49\u201354.", "ArticleIdList": ["21430339"]}, {"Citation": "Sairazi N.S., Sirajudeen K.N.S. Natural products and their bioactive compounds: Neuroprotective potentials against neurodegenerative diseases. Evid. Based Complement. Alternat. Med. 2020;2020:6565396.", "ArticleIdList": ["PMC7042511", "32148547"]}, {"Citation": "Sun A.Y., Wang Q., Simonyi A., Sun G.Y. 2015. Botanical phenolics and neurodegeneration.", "ArticleIdList": ["22593921"]}, {"Citation": "Syad A.N., Devi K.P. Botanics: a potential source of new therapies for Alzheimer\u2019s disease. Botanics. 2014;4:11\u201316."}, {"Citation": "Costa I.M., Lima F.O.V., Fernandes L.C.B., Norrara B., Neta F.I., Alves R.D., Cavalcanti J., Lucena E.E.S., Cavalcante J.S., Rego A.C.M., Filho I.A., Queiroz D.B., Freire M.A.M., Guzen F.P. Astragaloside IV supplementation promotes a neuroprotective effect in experimental models of neurological disorders: A systematic review. Curr. Neuropharmacol. 2019;17(7):648\u2013665.", "ArticleIdList": ["PMC6712289", "30207235"]}, {"Citation": "Gupta V., Sharma B. Forensic applications of Indian traditional toxic plants and their constituents. Forensic Res Criminol Int J. 2017;4(1):00101."}, {"Citation": "Maia M.A., Sousa E. BACE-1 and \u03b3-Secretase as therapeutic targets for Alzheimer\u2019s disease. Pharmaceuticals. 2019;12(1):41.", "ArticleIdList": ["PMC6469197", "30893882"]}, {"Citation": "Prasansuklab A., Tencomnao T. Amyloidosis in Alzheimer\u2019s disease: The toxicity of amyloid beta (A \u03b2), mechanisms of its accumulation and implications of medicinal plants for therapy. Evid. Based Complement. Alternat. Med. 2013;2013:413808\u2013413808.", "ArticleIdList": ["PMC3671299", "23762130"]}, {"Citation": "Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer\u2019s disease. CNS Neurol. Disord. Drug Targets. 2009;8(1):16\u201330.", "ArticleIdList": ["PMC2872930", "19275634"]}, {"Citation": "Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003;9(7):907\u2013913.", "ArticleIdList": ["12808450"]}, {"Citation": "Selkoe D.J. Clearing the brain\u2019s amyloid cobwebs. Neuron. 2001;32(2):177\u2013180.", "ArticleIdList": ["11683988"]}, {"Citation": "Butterfield D.A., Reed T., Newman S.F., Sultana R. Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer\u2019s disease and mild cognitive impairment. Free Radic. Biol. Med. 2007;43(5):658\u2013677.", "ArticleIdList": ["PMC2031860", "17664130"]}, {"Citation": "Canevari L., Clark J.B., Bates T.E. \u03b2-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 1999;457(1):131\u2013134.", "ArticleIdList": ["10486579"]}, {"Citation": "Lin H., Bhatia R., Lal R. Amyloid beta protein forms ion channels: implications for Alzheimer\u2019s disease pathophysiology. FASEB J. 2001;15(13):2433\u20132444.", "ArticleIdList": ["11689468"]}, {"Citation": "Parameshwaran K., Dhanasekaran M., Suppiramaniam V. Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp. Neurol. 2008;210(1):7\u201313.", "ArticleIdList": ["18053990"]}, {"Citation": "Rosales-Corral S., Tan D.X., Reiter R.J., Valdivia-Vel\u00e1zquez M., Acosta-Mart\u00ednez J.P., Ortiz G.G. Kinetics of the neuroinflammation-oxidative stress correlation in rat brain following the injection of fibrillar amyloid-beta onto the hippocampus in vivo. J. Neuroimmunol. 2004;150(1-2):20\u201328.", "ArticleIdList": ["15081245"]}, {"Citation": "Butterfield D.A. Perspectives on oxidative stress in Alzheimer\u2019s disease and predictions of future research emphases. J. Alzheimers Dis. 2018;64:S469\u2013S479.", "ArticleIdList": ["29504538"]}, {"Citation": "Chakrabarti S., Sinha M., Thakurta I.G., Banerjee P., Chattopadhyay M. Oxidative stress and amyloid beta toxicity in Alzheimer\u2019s disease: intervention in a complex relationship by antioxidants. Curr. Med. Chem. 2013;20(37):4648\u20134664.", "ArticleIdList": ["23834172"]}, {"Citation": "Santos J.R., Gois A.M., Mendon\u00e7a D.M.F., Freire M.A.M. Nutritional status, oxidative stress and dementia: the role of selenium in Alzheimer\u2019s disease. Front. Aging Neurosci. 2014;6:206\u2013206.", "ArticleIdList": ["PMC4147716", "25221506"]}, {"Citation": "Ansari M.A., Scheff S.W. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic. Biol. Med. 2011;51(1):171\u2013178.", "ArticleIdList": ["PMC3109185", "21457777"]}, {"Citation": "Jiang T., Sun Q., Chen S. Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson\u2019s disease and Alzheimer\u2019s disease. Prog. Neurobiol. 2016;147:1\u201319.", "ArticleIdList": ["27769868"]}, {"Citation": "Griffin W.S. Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 2006;83(2):470s\u2013474s.", "ArticleIdList": ["16470015"]}, {"Citation": "Wang J.Z., Xia Y.Y., Grundke-Iqbal I., Iqbal K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J. Alzheimers Dis. 2013;33(Suppl. 1):S123\u2013S139.", "ArticleIdList": ["22710920"]}, {"Citation": "Keskin A.O., Durmaz N., Uncu G., Erzurumluoglu E., Y\u0131ld\u0131r\u0131m Z., Tuncer N., Adap\u0131nar D.\u00d6. In: Geriatric medicine and gerontology. Edward T.Z.J., editor. London, UK: IntechOpen; 2019. Future treatment of Alzheimer disease."}, {"Citation": "Christensen D.D. Changing the course of Alzheimer\u2019s disease: anti-amyloid disease-modifying treatments on the horizon. Prim. Care Companion J. Clin. Psychiatry. 2007;9(1):32\u201341.", "ArticleIdList": ["PMC1894844", "17599166"]}, {"Citation": "Chen G-f., Xu T-h., Yan Y., Zhou Y-r., Jiang Y., Melcher K., Xu H.E. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 2017;38(9):1205\u20131235.", "ArticleIdList": ["PMC5589967", "28713158"]}, {"Citation": "Spencer B., Masliah E. Immunotherapy for Alzheimer\u2019s disease: past, present and future. Front. Aging Neurosci. 2014;6(114)", "ArticleIdList": ["PMC4051211", "24959143"]}, {"Citation": "Vassar R., Kandalepas P.C. The \u03b2-secretase enzyme BACE1 as a therapeutic target for Alzheimer\u2019s disease. Alzheimers Res. Ther. 2011;3(3):20.", "ArticleIdList": ["PMC3226309", "21639952"]}, {"Citation": "Hampel H., Vassar R., De Strooper B., Hardy J., Willem M., Singh N., Zhou J., Yan R., Vanmechelen E., De Vos A., Nistic\u00f2 R., Corbo M., Imbimbo B.P., Streffer J., Voytyuk I., Timmers M., Tahami Monfared A.A., Irizarry M., Albala B., Koyama A., Watanabe N., Kimura T., Yarenis L., Lista S., Kramer L., Vergallo A. The \u03b2-Secretase BACE1 in Alzheimer\u2019s disease. Biol. Psychiatry. 2020", "ArticleIdList": ["PMC7533042", "32223911"]}, {"Citation": "Dominguez D., Tournoy J., Hartmann D., Huth T., Cryns K., Deforce S., Serneels L., Camacho I.E., Marjaux E., Craessaerts K., Roebroek A.J., Schwake M., D\u2019Hooge R., Bach P., Kalinke U., Moechars D., Alzheimer C., Reiss K., Saftig P., De Strooper B. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J. Biol. Chem. 2005;280(35):30797\u201330806.", "ArticleIdList": ["15987683"]}, {"Citation": "Harrison S.M., Harper A.J., Hawkins J., Duddy G., Grau E., Pugh P.L., Winter P.H., Shilliam C.S., Hughes Z.A., Dawson L.A., Gonzalez M.I., Upton N., Pangalos M.N., Dingwall C. BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes. Mol. Cell. Neurosci. 2003;24(3):646\u2013655.", "ArticleIdList": ["14664815"]}, {"Citation": "Luo Y., Bolon B., Kahn S., Bennett B.D., Babu-Khan S., Denis P., Fan W., Kha H., Zhang J., Gong Y., Martin L., Louis J.C., Yan Q., Richards W.G., Citron M., Vassar R. Mice deficient in BACE1, the Alzheimer\u2019s beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 2001;4(3):231\u2013232.", "ArticleIdList": ["11224535"]}, {"Citation": "Ghosh A.K., Osswald H.L. BACE1 (\u03b2-secretase) inhibitors for the treatment of Alzheimer\u2019s disease. Chem. Soc. Rev. 2014;43(19):6765\u20136813.", "ArticleIdList": ["PMC4159447", "24691405"]}, {"Citation": "Avila J. Tau phosphorylation and aggregation in Alzheimer\u2019s disease pathology. FEBS Lett. 2006;580(12):2922\u20132927.", "ArticleIdList": ["16529745"]}, {"Citation": "Martin L., Latypova X., Terro F. Post-translational modifications of tau protein: implications for Alzheimer\u2019s disease. Neurochem. Int. 2011;58(4):458\u2013471.", "ArticleIdList": ["21215781"]}, {"Citation": "Martin L., Latypova X., Wilson C.M., Magnaudeix A., Perrin M.L., Yardin C., Terro F. Tau protein kinases: involvement in Alzheimer\u2019s disease. Ageing Res. Rev. 2013;12(1):289\u2013309.", "ArticleIdList": ["22742992"]}, {"Citation": "Hilgeroth A., Tell V. Recent developments of protein kinase inhibitors as potential AD therapeutics. Front. Cell. Neurosci. 2013;7(189)", "ArticleIdList": ["PMC3832900", "24312003"]}, {"Citation": "Zhang Z., Song M., Liu X., Kang S.S., Kwon I-S., Duong D.M., Seyfried N.T., Hu W.T., Liu Z., Wang J-Z., Cheng L., Sun Y.E., Yu S.P., Levey A.I., Ye K. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer\u2019s disease. Nat. Med. 2014;20(11):1254\u20131262.", "ArticleIdList": ["PMC4224595", "25326800"]}, {"Citation": "Cohen T.J., Guo J.L., Hurtado D.E., Kwong L.K., Mills I.P., Trojanowski J.Q., Lee V.M.Y. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat. Commun. 2011;2(1):252.", "ArticleIdList": ["PMC3120096", "21427723"]}, {"Citation": "Barten D.M., Fanara P., Andorfer C., Hoque N., Wong P.Y.A., Husted K.H., Cadelina G.W., Decarr L.B., Yang L., Liu V., Fessler C., Protassio J., Riff T., Turner H., Janus C.G., Sankaranarayanan S., Polson C., Meredith J.E., Gray G., Hanna A., Olson R.E., Kim S-H., Vite G.D., Lee F.Y., Albright C.F. Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. J. Neurosci. 2012;32(21):7137\u20137145.", "ArticleIdList": ["PMC6622320", "22623658"]}, {"Citation": "Azam F., Alabdullah N.H., Ehmedat H.M., Abulifa A.R., Taban I., Upadhyayula S. NSAIDs as potential treatment option for preventing amyloid \u03b2 toxicity in Alzheimer\u2019s disease: an investigation by docking, molecular dynamics, and DFT studies. J. Biomol. Struct. Dyn. 2018;36(8):2099\u20132117.", "ArticleIdList": ["28571516"]}, {"Citation": "Lim G.P., Yang F., Chu T., Chen P., Beech W., Teter B., Tran T., Ubeda O., Ashe K.H., Frautschy S. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer\u2019s disease. J. Neurosci. 2000;20(15):5709\u20135714.", "ArticleIdList": ["PMC6772529", "10908610"]}, {"Citation": "Netland E.E., Newton J.L., Majocha R.E., Tate B.A. Indomethacin Reverses the Microglial Response to Amyloid \u03b2-Protein. Neurobiol. Aging. 1998;19(3):201\u2013204.", "ArticleIdList": ["9661994"]}, {"Citation": "Yan Q., Zhang J., Liu H., Babu-Khan S., Vassar R., Biere A.L., Citron M., Landreth G. Anti-inflammatory drug therapy alters \u03b2-amyloid processing and deposition in an animal model of Alzheimer\u2019s disease. J. Neurosci. 2003;23(20):7504\u20137509.", "ArticleIdList": ["PMC6740758", "12930788"]}, {"Citation": "Gravina S.A., Ho L., Eckman C.B., Long K.E., Otvos L., Jr, Younkin L.H., Suzuki N., Younkin S.G. Amyloid beta protein (A beta) in Alzheimer\u2019s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J. Biol. Chem. 1995;270(13):7013\u20137016.", "ArticleIdList": ["7706234"]}, {"Citation": "Gu L., Guo Z. Alzheimer\u2019s A\u03b242 and A\u03b240 peptides form interlaced amyloid fibrils. J. Neurochem. 2013;126(3):305\u2013311.", "ArticleIdList": ["PMC3716832", "23406382"]}, {"Citation": "Eriksen J.L., Sagi S.A., Smith T.E., Weggen S., Das P., McLendon D.C., Ozols V.V., Jessing K.W., Zavitz K.H., Koo E.H., Golde T.E. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J. Clin. Invest. 2003;112(3):440\u2013449.", "ArticleIdList": ["PMC166298", "12897211"]}, {"Citation": "Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Bulter T., Kang D.E., Marquez-Sterling N., Golde T.E., Koo E.H. A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity. Nature. 2001;414(6860):212\u2013216.", "ArticleIdList": ["11700559"]}, {"Citation": "Szekely C.A., Green R.C., Breitner J.C.S., \u00d8stbye T., Beiser A.S., Corrada M.M., Dodge H.H., Ganguli M., Kawas C.H., Kuller L.H., Psaty B.M., Resnick S.M., Wolf P.A., Zonderman A.B., Welsh-Bohmer K.A., Zandi P.P. No advantage of A\u03b2<sub>42</sub>-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology. 2008;70(24):2291\u20132298.", "ArticleIdList": ["PMC2755238", "18509093"]}, {"Citation": "Breitner J.C., Haneuse S.J., Walker R., Dublin S., Crane P.K., Gray S.L., Larson E.B. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology. 2009;72(22):1899\u20131905.", "ArticleIdList": ["PMC2690966", "19386997"]}, {"Citation": "Chang C-W., Horng J-T., Hsu C-C., Chen J-M. Mean daily dosage of aspirin and the risk of incident Alzheimer\u2019s dementia in patients with type 2 diabetes mellitus: A Nationwide retrospective cohort study in Taiwan. J. Diabetes Res. 2016;2016:9027484.", "ArticleIdList": ["PMC5102734", "27868071"]}, {"Citation": "C\u00f4t\u00e9 S., Carmichael P.H., Verreault R., Lindsay J., Lefebvre J., Laurin D. Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 2012;8(3):219\u2013226.", "ArticleIdList": ["22546354"]}, {"Citation": "Choi S-H., Bosetti F. Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid. Aging (Albany NY) 2009;1(2):234\u2013244.", "ArticleIdList": ["PMC2806008", "20157512"]}, {"Citation": "Kotilinek L.A., Westerman M.A., Wang Q., Panizzon K., Lim G.P., Simonyi A., Lesne S., Falinska A., Younkin L.H., Younkin S.G., Rowan M., Cleary J., Wallis R.A., Sun G.Y., Cole G., Frautschy S., Anwyl R., Ashe K.H. Cyclooxygenase-2 inhibition improves amyloid-\u03b2-mediated suppression of memory and synaptic plasticity. Brain. 2008;131(3):651\u2013664.", "ArticleIdList": ["PMC2628581", "18292081"]}, {"Citation": "Woodling N.S., Andreasson K.I. Untangling the web: Toxic and protective effects of neuroinflammation and PGE2 signaling in Alzheimer\u2019s disease. ACS Chem. Neurosci. 2016;7(4):454\u2013463.", "ArticleIdList": ["PMC5239037", "26979823"]}, {"Citation": "Singh M. In: Encyclopedia of Neuroscience. Squire L.R., editor. Oxford, UK: Academic Press; 2009. Neuroprotection: Pharmacological approaches. pp. 967\u2013970."}, {"Citation": "Carrillo-Mora P., Silva-Adaya D., Villase\u00f1or-Aguayo K. Glutamate in Parkinson\u2019s disease: Role of antiglutamatergic drugs. Basal Ganglia. 2013;3(3):147\u2013157."}, {"Citation": "Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460(2):525\u2013542.", "ArticleIdList": ["20229265"]}, {"Citation": "Pi\u00f1a-Crespo J.C., Sanz-Blasco S., Lipton S.A. In: Handbook of Neurotoxicity. Kostrzewa R., editor. New York, US: Springer; 2014. Concept of excitotoxicity via glutamate receptors."}, {"Citation": "Kritis A.A., Stamoula E.G., Paniskaki K.A., Vavilis T.D. Researching glutamate-induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front. Cell. Neurosci. 2015;9(91)", "ArticleIdList": ["PMC4362409", "25852482"]}, {"Citation": "Campos-Pe\u00f1a V., Meraz-R\u00edos M.A. Alzheimer disease: The role of A\u03b2 in the glutamatergic system. Neurochem. 2014;23:285\u2013315."}, {"Citation": "Aarts M.M., Tymianski M. Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors. Biochem. Pharmacol. 2003;66(6):877\u2013886.", "ArticleIdList": ["12963474"]}, {"Citation": "Freire M. Pathophysiology of neurodegeneration following traumatic brain injury. West Indian Med. J. 2012;61(7)", "ArticleIdList": ["23620976"]}, {"Citation": "Hynd M.R., Scott H.L., Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease. Neurochem. Int. 2004;45(5):583\u2013595.", "ArticleIdList": ["15234100"]}, {"Citation": "Moritani T., Smoker W.R., Sato Y., Numaguchi Y., Westesson P-L.A. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am. J. Neuroradiol. 2005;26(2):216\u2013228.", "ArticleIdList": ["PMC7974100", "15709116"]}, {"Citation": "Van Laar V.S., Roy N., Liu A., Rajprohat S., Arnold B., Dukes A.A., Holbein C.D., Berman S.B. Glutamate excitotoxicity in neurons triggers mitochondrial and endoplasmic reticulum accumulation of Parkin, and, in the presence of N-acetyl cysteine, mitophagy. Neurobiol. Dis. 2015;74:180\u2013193.", "ArticleIdList": ["PMC4322770", "25478815"]}, {"Citation": "Beal M.F. Excitotoxicity and nitric oxide in parkinson\u2019s disease pathogenesis. Ann. Neurol. 1998;44(S1):S110\u2013S114.", "ArticleIdList": ["9749581"]}, {"Citation": "Helton T.D., Otsuka T., Lee M.C., Mu Y., Ehlers M.D. Pruning and loss of excitatory synapses by the parkin ubiquitin ligase. Proc. Natl. Acad. Sci. USA. 2008;105(49):19492\u201319497.", "ArticleIdList": ["PMC2614788", "19033459"]}, {"Citation": "Kutzing M.K., Luo V., Firestein B.L. Protection from glutamate-induced excitotoxicity by memantine. Ann. Biomed. Eng. 2012;40(5):1170\u20131181.", "ArticleIdList": ["PMC4217523", "22203191"]}, {"Citation": "Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat. Rev. Drug Discov. 2006;5(2):160\u2013170.", "ArticleIdList": ["16424917"]}, {"Citation": "Wrighton D.C., Baker E.J., Chen P.E., Wyllie D.J. Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J. Physiol. 2008;586(1):211\u2013225.", "ArticleIdList": ["PMC2375557", "17962329"]}, {"Citation": "Hardingham G.E., Fukunaga Y., Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 2002;5(5):405\u2013414.", "ArticleIdList": ["11953750"]}, {"Citation": "Johnson K.A., Conn P.J., Niswender C.M. Glutamate receptors as therapeutic targets for Parkinson\u2019s disease. CNS Neurol. Disord. Drug Targets. 2009;8(6):475\u2013491.", "ArticleIdList": ["PMC3005251", "19702565"]}, {"Citation": "Martin L.J., Blackstone C.D., Levey A.I., Huganir R.L., Price D.L. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience. 1993;53(2):327\u2013358.", "ArticleIdList": ["8388083"]}, {"Citation": "Hollmann M., Hartley M., Heinemann S. Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition. Science. 1991;252(5007):851\u2013853.", "ArticleIdList": ["1709304"]}, {"Citation": "Tamano H., Morioka H., Nishio R., Takeuchi A., Takeda A. AMPA-induced extracellular Zn(2+) influx into nigral dopaminergic neurons causes movement disorder in rats. Neurotoxicology. 2018;69:23\u201328.", "ArticleIdList": ["30176255"]}, {"Citation": "Zhang Z., Zhang S., Fu P., Zhang Z., Lin K., Ko J.K-S., Yung K.K-L. Roles of glutamate receptors in Parkinson\u2019s disease. Int. J. Mol. Sci. 2019;20(18):4391.", "ArticleIdList": ["PMC6769661", "31500132"]}, {"Citation": "Kumar N.S., Nisha N. Phytomedicines as potential inhibitors of \u03b2 amyloid aggregation: significance to Alzheimer\u2019s disease. Chin. J. Nat. Med. 2014;12(11):801\u2013818.", "ArticleIdList": ["25480511"]}, {"Citation": "Murray A.P., Faraoni M.B., Castro M.J., Alza N.P., Cavallaro V. Natural AChE inhibitors from plants and their contribution to Alzheimer\u2019s disease therapy. Curr. Neuropharmacol. 2013;11(4):388\u2013413.", "ArticleIdList": ["PMC3744903", "24381530"]}, {"Citation": "Neta F.I., Da Costa I.M., Lima F.O.V., Fernandes L.C.B., De Paiva Cavalcanti J.R.L., De Moura Freire M.A., De Souza Lucena E.E., Do R\u00eago A.C.M., De Azevedo E.P., Guzen F.P. Effects of Mucuna pruriens (L.) supplementation on experimental models of Parkinson\u2019s disease: A systematic review. Pharmacogn. Rev. 2018;12(23)"}, {"Citation": "Ryan P., Patel B., Makwana V., Jadhav H.R., Kiefel M., Davey A., Reekie T.A., Rudrawar S., Kassiou M. Peptides, peptidomimetics, and carbohydrate-peptide conjugates as amyloidogenic aggregation inhibitors for Alzheimer\u2019s disease. ACS Chem. Neurosci. 2018;9(7):1530\u20131551.", "ArticleIdList": ["29782794"]}, {"Citation": "L\u00fchrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., D\u00f6beli H., Schubert D., Riek R. 3D structure of Alzheimer\u2019s amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA. 2005;102(48):17342\u201317347.", "ArticleIdList": ["PMC1297669", "16293696"]}, {"Citation": "Velander P., Wu L., Henderson F., Zhang S., Bevan D.R., Xu B. Natural product-based amyloid inhibitors. Biochem. Pharmacol. 2017;139:40\u201355.", "ArticleIdList": ["PMC5841551", "28390938"]}, {"Citation": "LeVine H., III Thioflavine T interaction with synthetic Alzheimer\u2019s disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993;2(3):404\u2013410.", "ArticleIdList": ["PMC2142377", "8453378"]}, {"Citation": "Groenning M. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current status. J. Chem. Biol. 2010;3(1):1\u201318.", "ArticleIdList": ["PMC2816742", "19693614"]}, {"Citation": "Porzoor A., Alford B., H\u00fcgel H.M., Grando D., Caine J., Macreadie I. Anti-amyloidogenic properties of some phenolic compounds. Biomolecules. 2015;5(2)", "ArticleIdList": ["PMC4496683", "25898401"]}, {"Citation": "Yu M., Chen X., Liu J., Ma Q., Zhuo Z., Chen H., Zhou L., Yang S., Zheng L., Ning C., Xu J., Gao T., Hou S.T. Gallic acid disruption of A\u03b2(1-42) aggregation rescues cognitive decline of APP/PS1 double transgenic mouse. Neurobiol. Dis. 2019;124:67\u201380.", "ArticleIdList": ["30447302"]}, {"Citation": "Polito C.A., Cai Z-Y., Shi Y-L., Li X-M., Yang R., Shi M., Li Q-S., Ma S-C., Xiang L-P., Wang K-R., Ye J-H., Lu J-L., Zheng X-Q., Liang Y-R. Association of tea consumption with risk of Alzheimer\u2019s disease and anti-beta-amyloid effects of tea. Nutrients. 2018;10(5)", "ArticleIdList": ["PMC5986534", "29789466"]}, {"Citation": "Kesse-Guyot E., Fezeu L., Andreeva V.A., Touvier M., Scalbert A., Hercberg S., Galan P. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. J. Nutr. 2011;142(1):76\u201383.", "ArticleIdList": ["22090468"]}, {"Citation": "Gauci A.J., Caruana M., Giese A., Scerri C., Vassallo N. Identification of polyphenolic compounds and black tea extract as potent inhibitors of lipid membrane destabilization by A\u03b2 42 aggregates. J. Alzheimers Dis. 2011;27(4):767\u2013779.", "ArticleIdList": ["21891862"]}, {"Citation": "Ma H., Johnson S.L., Liu W., DaSilva N.A., Meschwitz S., Dain J.A., Seeram N.P. Evaluation of polyphenol anthocyanin-enriched extracts of blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry for free radical scavenging, reactive carbonyl species trapping, anti-glycation, anti-\u03b2-amyloid aggregation, and microglial neuroprotective effects. Int. J. Mol. Sci. 2018;19(2)", "ArticleIdList": ["PMC5855683", "29401686"]}, {"Citation": "Shin S.J., Jeong Y., Jeon S.G., Kim S., Lee S.K., Choi H.S., Im C.S., Kim S.H., Kim S.H., Park J.H., Kim J.I., Kim J.J., Moon M. Uncaria rhynchophylla ameliorates amyloid beta deposition and amyloid beta-mediated pathology in 5XFAD mice. Neurochem. Int. 2018;121:114\u2013124.", "ArticleIdList": ["30291956"]}, {"Citation": "Sabaragamuwa R., Perera C.O., Fedrizzi B. Centella asiatica (Gotu kola) as a neuroprotectant and its potential role in healthy ageing. Trends Food Sci. Technol. 2018;79:88\u201397."}, {"Citation": "Ahuja M., Patel M., Majrashi M., Mulabagal V., Dhanasekaran M. 2017. Centella asiatica, an Ayurvedic medicinal plant, prevents the major neurodegenerative and neurotoxic mechanisms associated with cognitive impairment."}, {"Citation": "Firdaus Z., Singh N., Prajapati S.K., Krishnamurthy S., Singh T.D. Centella asiatica prevents D-galactose-Induced cognitive deficits, oxidative stress and neurodegeneration in the adult rat brain. Drug Chem. Toxicol. 2020;\u2022\u2022\u2022:1\u201310.", "ArticleIdList": ["33078641"]}, {"Citation": "Zhang X., Wang X., Hu X., Chu X., Li X., Han F. Neuroprotective effects of a Rhodiola crenulata extract on amyloid-\u03b2 peptides (A\u03b2(1-42)) -induced cognitive deficits in rat models of Alzheimer\u2019s disease. Phytomedicine. 2019;57:331\u2013338.", "ArticleIdList": ["30807987"]}, {"Citation": "Wu C.R., Lin H.C., Su M.H. Reversal by aqueous extracts of Cistanche tubulosa from behavioral deficits in Alzheimer\u2019s disease-like rat model: relevance for amyloid deposition and central neurotransmitter function. BMC Complement. Altern. Med. 2014;14:202.", "ArticleIdList": ["PMC4227081", "24968859"]}, {"Citation": "Dhouafli Z., Cuanalo-Contreras K., Hayouni E.A., Mays C.E., Soto C., Moreno-Gonzalez I. Inhibition of protein misfolding and aggregation by natural phenolic compounds. Cell. Mol. Life Sci. 2018;75(19):3521\u20133538.", "ArticleIdList": ["30030591"]}, {"Citation": "Khan A.N., Hassan M.N., Khan R.H. Gallic acid: A naturally occurring bifunctional inhibitor of amyloid and metal induced aggregation with possible implication in metal-based therapy. J. Mol. Liq. 2019;285:27\u201337."}, {"Citation": "Liu Y., Carver J.A., Calabrese A.N., Pukala T.L. Gallic acid interacts with \u03b1-synuclein to prevent the structural collapse necessary for its aggregation. Biochim. Biophys. Acta. Proteins Proteomics. 2014;1844(9):1481\u20131485.", "ArticleIdList": ["24769497"]}, {"Citation": "Liu Y., Pukala T.L., Musgrave I.F., Williams D.M., Dehle F.C., Carver J.A. Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation. Bioorg. Med. Chem. Lett. 2013;23(23):6336\u20136340.", "ArticleIdList": ["24157371"]}, {"Citation": "Wong D.Y., Musgrave I.F., Harvey B.S., Smid S.D. A\u00e7a\u00ed (Euterpe oleraceae Mart.) berry extract exerts neuroprotective effects against \u03b2-amyloid exposure in vitro. Neurosci. Lett. 2013;556:221\u2013226.", "ArticleIdList": ["24161892"]}, {"Citation": "Ban J.Y., Nguyen H.T., Lee H.J., Cho S.O., Ju H.S., Kim J.Y., Bae K., Song K.S., Seong Y.H. Neuroprotective properties of gallic acid from Sanguisorbae radix on amyloid beta protein (25--35)-induced toxicity in cultured rat cortical neurons. Biol. Pharm. Bull. 2008;31(1):149\u2013153.", "ArticleIdList": ["18175960"]}, {"Citation": "Fujiwara H., Tabuchi M., Yamaguchi T., Iwasaki K., Furukawa K., Sekiguchi K., Ikarashi Y., Kudo Y., Higuchi M., Saido T.C. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1, 2, 3, 4, 6\u2010penta\u2010O\u2010galloyl\u2010\u03b2\u2010d\u2010glucopyranose have potent anti\u2010aggregation effects on Alzheimer\u2019s amyloid \u03b2 proteins in vitro and in vivo. J. Neurochem. 2009;109(6):1648\u20131657.", "ArticleIdList": ["19457098"]}, {"Citation": "Stefanescu R., Stanciu G.D., Luca A., Paduraru L., Tamba B-I. Secondary metabolites from plants possessing inhibitory properties against beta-amyloid aggregation as revealed by Thioflavin-T assay and correlations with investigations on transgenic mouse models of Alzheimer\u2019s disease. Biomolecules. 2020;10(6):870.", "ArticleIdList": ["PMC7355648", "32517180"]}, {"Citation": "Ono K., Hasegawa K., Naiki H., Yamada M. Curcumin has potent anti\u2010amyloidogenic effects for Alzheimer\u2019s \u03b2\u2010amyloid fibrils in vitro. J. Neurosci. Res. 2004;75(6):742\u2013750.", "ArticleIdList": ["14994335"]}, {"Citation": "Takahashi R., Ono K., Takamura Y., Mizuguchi M., Ikeda T., Nishijo H., Yamada M. Phenolic compounds prevent the oligomerization of \u03b1\u2010synuclein and reduce synaptic toxicity. J. Neurochem. 2015;134(5):943\u2013955.", "ArticleIdList": ["26016728"]}, {"Citation": "Rong H., Liang Y., Niu Y. Rosmarinic acid attenuates \u03b2-amyloid-induced oxidative stress via Akt/GSK-3\u03b2/Fyn-mediated Nrf2 activation in PC12 cells. Free Radic. Biol. Med. 2018;120:114\u2013123.", "ArticleIdList": ["29555592"]}, {"Citation": "Sun J., Jiang G., Shigemori H. Inhibitory activity on amyloid aggregation of rosmarinic acid and Its substructures from Isodon japonicus. 2019."}, {"Citation": "Hamaguchi T., Ono K., Murase A., Yamada M. Phenolic compounds prevent Alzheimer\u2019s pathology through different effects on the amyloid-beta aggregation pathway. Am. J. Pathol. 2009;175(6):2557\u20132565.", "ArticleIdList": ["PMC2789642", "19893028"]}, {"Citation": "Khorshidi F., Poljak A., Liu Y., Lo J.W., Crawford J.D., Sachdev P.S. Resveratrol: a \u201cmiracle\u201d drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis. Ageing Res. Rev. 2020;\u2022\u2022\u2022:101199", "ArticleIdList": ["33303422"]}, {"Citation": "de la Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 2007;35(Pt 5):1156\u20131160.", "ArticleIdList": ["17956300"]}, {"Citation": "Al-Edresi S., Alsalahat I., Freeman S., Aojula H., Penny J. Resveratrol-mediated cleavage of amyloid \u03b21-42 peptide: potential relevance to Alzheimer\u2019s disease. Neurobiol. Aging. 2020;94:24\u201333.", "ArticleIdList": ["32512325"]}, {"Citation": "Conte A., Pellegrini S., Tagliazucchi D. Synergistic protection of PC12 cells from \u03b2-amyloid toxicity by resveratrol and catechin. Brain Res. Bull. 2003;62(1):29\u201338.", "ArticleIdList": ["14596889"]}, {"Citation": "Chiang M-C., Nicol C.J., Cheng Y-C. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress. Neurochem. Int. 2018;115:1\u201310.", "ArticleIdList": ["28989083"]}, {"Citation": "Sciacca M.F.M., Chillemi R., Sciuto S., Greco V., Messineo C., Kotler S.A., Lee D-K., Brender J.R., Ramamoorthy A., La Rosa C., Milardi D. A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage. Biochim. Biophys. Acta Biomembr. 2018;1860(9):1793\u20131802.", "ArticleIdList": ["29555190"]}, {"Citation": "Feng Y., Wang X-p., Yang S-g., Wang Y-j., Zhang X., Du X-t., Sun X-x., Zhao M., Huang L., Liu R-t. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. Neurotoxicology. 2009;30(6):986\u2013995.", "ArticleIdList": ["19744518"]}, {"Citation": "Liu R., Gao M., Qiang G.F., Zhang T.T., Lan X., Ying J., Du G.H. The anti-amnesic effects of luteolin against amyloid \u03b225-35 peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience. 2009;162(4):1232\u20131243.", "ArticleIdList": ["19442706"]}, {"Citation": "Akaishi T., Morimoto T., Shibao M., Watanabe S., Sakai-Kato K., Utsunomiya-Tate N., Abe K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci. Lett. 2008;444(3):280\u2013285.", "ArticleIdList": ["18761054"]}, {"Citation": "Churches Q.I., Caine J., Cavanagh K., Epa V.C., Waddington L., Tranberg C.E., Meyer A.G., Varghese J.N., Streltsov V., Duggan P.J. Naturally occurring polyphenolic inhibitors of amyloid beta aggregation. Bioorg. Med. Chem. Lett. 2014;24(14):3108\u20133112.", "ArticleIdList": ["24878198"]}, {"Citation": "Sawmiller D., Li S., Shahaduzzaman M., Smith A.J., Obregon D., Giunta B., Borlongan C.V., Sanberg P.R., Tan J. Luteolin reduces Alzheimer\u2019s disease pathologies induced by traumatic brain injury. Int. J. Mol. Sci. 2014;15(1):895\u2013904.", "ArticleIdList": ["PMC3907845", "24413756"]}, {"Citation": "Zhang J-X., Xing J-G., Wang L-L., Jiang H-L., Guo S-L., Liu R. Luteolin inhibits fibrillary \u03b2-amyloid1-40-induced inflammation in a human blood-brain barrier model by suppressing the p38 MAPK-mediated NF-\u03baB signaling pathways. Molecules. 2017;22(3):334.", "ArticleIdList": ["PMC6155314", "28245546"]}, {"Citation": "Bieschke J., Russ J., Friedrich R.P., Ehrnhoefer D.E., Wobst H., Neugebauer K., Wanker E.E. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA. 2010;107(17):7710\u20137715.", "ArticleIdList": ["PMC2867908", "20385841"]}, {"Citation": "Cao P., Raleigh D.P. Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry. 2012;51(13):2670\u20132683.", "ArticleIdList": ["PMC3329122", "22409724"]}, {"Citation": "Ehrnhoefer D.E., Duennwald M., Markovic P., Wacker J.L., Engemann S., Roark M., Legleiter J., Marsh J.L., Thompson L.M., Lindquist S., Muchowski P.J., Wanker E.E. Green tea (\u2212)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington\u2019s disease models. Hum. Mol. Genet. 2006;15(18):2743\u20132751.", "ArticleIdList": ["16893904"]}, {"Citation": "DeTure M.A., Dickson D.W. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol. Neurodegener. 2019;14(1):32.", "ArticleIdList": ["PMC6679484", "31375134"]}, {"Citation": "Mereles D., Buss S.J., Hardt S.E., Hunstein W., Katus H.A. Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis. Clin. Res. Cardiol. 2010;99(8):483\u2013490.", "ArticleIdList": ["20221615"]}, {"Citation": "Luvone T., De Filippis D., Esposito G., D\u2019Amico A., Izzo A.A. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-\u03b2 peptide-induced neurotoxicity. J. Pharmacol. Exp. Ther. 2006;317(3):1143\u20131149.", "ArticleIdList": ["16495207"]}, {"Citation": "Zhou Y-Q., Yang Z-L., Xu L., Li P., Hu Y-Z. Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-\u03b2 induced cytotoxicity. Cell Biol. Int. 2009;33(10):1102\u20131110.", "ArticleIdList": ["19615455"]}, {"Citation": "Jayaprakasam B., Padmanabhan K., Nair M.G. Withanamides in Withania somnifera fruit protect PC\u201012 cells from \u03b2\u2010amyloid responsible for Alzheimer\u2019s disease. Phytother. Res. 2010;24(6):859\u2013863.", "ArticleIdList": ["19957250"]}, {"Citation": "Ho C.C., Kumaran A., Hwang L.S. Bio-assay guided isolation and identification of anti-Alzheimer active compounds from the root of Angelica sinensis. Food Chem. 2009;114(1):246\u2013252."}, {"Citation": "Kim D.H., Park S.J., Kim J.M., Jeon S.J., Kim D-H., Cho Y-W., Son K.H., Lee H.J., Moon J-H., Cheong J.H., Ko K.H., Ryu J.H. Cognitive dysfunctions induced by a cholinergic blockade and A\u03b225-35 peptide are attenuated by salvianolic acid B. Neuropharmacology. 2011;61(8):1432\u20131440.", "ArticleIdList": ["21903108"]}, {"Citation": "Mei Z., Zhang F., Tao L., Zheng W., Cao Y., Wang Z., Tang S., Le K., Chen S., Pi R., Liu P. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates \u03b2-amyloid deposition through upregulating \u03b1-secretase in vivo and in vitro. Neurosci. Lett. 2009;452(2):90\u201395.", "ArticleIdList": ["19154776"]}, {"Citation": "Park S-Y., Kim D.S.H.L. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult:\u2009A drug discovery effort against Alzheimer\u2019s disease. J. Nat. Prod. 2002;65(9):1227\u20131231.", "ArticleIdList": ["12350137"]}, {"Citation": "Liu R., Meng F., Zhang L., Liu A., Qin H., Lan X., Li L., Du G. Luteolin isolated from the medicinal plant Elsholtzia rugulosa (Labiatae) prevents copper-mediated toxicity in \u03b2-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Molecules. 2011;16(3):2084\u20132096.", "ArticleIdList": ["PMC6259644", "21368720"]}, {"Citation": "Lee J.W., Lee Y.K., Lee B.J., Nam S-Y., Lee S.I., Kim Y.H., Kim K.H., Oh K-W., Hong J.T. Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid. Pharmacol. Biochem. Behav. 2010;95(1):31\u201340.", "ArticleIdList": ["20004682"]}, {"Citation": "Park H., Kang S., Nam E., Suh Y.H., Chang K.A. The protective effects of PSM-04 against beta amyloid-induced neurotoxicity in primary cortical neurons and an animal model of Alzheimer\u2019s disease. Front. Pharmacol. 2019;10:2.", "ArticleIdList": ["PMC6353859", "30733674"]}, {"Citation": "Choi S.J., Lee J-H., Heo H.J., Cho H.Y., Kim H.K., Kim C-J., Kim M.O., Suh S.H., Shin D-H. Punica granatum protects against oxidative stress in PC12 cells and oxidative stress-induced Alzheimer\u2019s symptoms in mice. J. Med. Food. 2011;14(7-8):695\u2013701.", "ArticleIdList": ["21631359"]}, {"Citation": "Wang R., Shen X., Xing E., Guan L., Xin L. Scutellaria baicalensis stem-leaf total flavonoid reduces neuronal apoptosis induced by amyloid beta-peptide (25-35). Neural Regen. Res. 2013;8(12):1081\u20131090.", "ArticleIdList": ["PMC4145899", "25206402"]}, {"Citation": "Na C.S., Hong S.S., Choi Y.H., Lee Y.H., Hong S.H., Lim J.Y., Kang B.H., Park S.Y., Lee D. Neuroprotective effects of constituents of Eragrostis ferruginea against A\u03b2-induced toxicity in PC12 cells. Arch. Pharm. Res. 2010;33(7):999\u20131003.", "ArticleIdList": ["20661708"]}, {"Citation": "Yang B., Han W., Han H., Liu Y., Guan W., Kuang H. Lignans from Schisandra chinensis rattan stems suppresses primary A\u03b2(1-42)-induced microglia activation via NF-\u03baB/MAPK signaling pathway. Nat. Prod. Res. 2019;33(18):2726\u20132729.", "ArticleIdList": ["29683353"]}, {"Citation": "Park S.Y., Lim J.Y., Jeong W., Hong S.S., Yang Y.T., Hwang B.Y., Lee D. C-methylflavonoids isolated from Callistemon lanceolatus protect PC12 cells against Abeta-induced toxicity. Planta Med. 2010;76(9):863\u2013868.", "ArticleIdList": ["20101562"]}, {"Citation": "Ma C.J., Kim Y.C., Sung S.H. Compounds with neuroprotective activity from the medicinal plant Machilus thunbergii. J Enzyme Inhib Med. 2009;24(5):1117\u20131121.", "ArticleIdList": ["19555186"]}, {"Citation": "Ammon H. Boswellic acids in chronic inflammatory diseases. Planta Med. 2006;72(12):1100\u20131116.", "ArticleIdList": ["17024588"]}, {"Citation": "Ding Y., Qiao Y., Wang M., Zhang H., Li L., Zhang Y., Ge J., Song Y., Li Y., Wen A. Enhanced neuroprotection of acetyl-11-keto-\u03b2-boswellic acid (AKBA)-loaded O-carboxymethyl chitosan nanoparticles through antioxidant and anti-inflammatory pathways. Mol. Neurobiol. 2016;53(6):3842\u20133853.", "ArticleIdList": ["26162321"]}, {"Citation": "Sadeghnia H.R., Arjmand F., Ghorbani A. Neuroprotective effect of Boswellia serrata and its active constituent acetyl 11-keto-\u03b2-boswellic acid against oxygen-glucose-serum deprivation-induced cell injury. Acta Pol. Pharm. 2017;74(3):911\u2013920.", "ArticleIdList": ["29513961"]}, {"Citation": "Rajabian A., Boroushaki M.T., Hayatdavoudi P., Sadeghnia H.R. Boswellia serrata protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells. DNA Cell Biol. 2016;35(11):666\u2013679.", "ArticleIdList": ["27494534"]}, {"Citation": "Rahimi V.B., Askari V.R., Mehrdad A., Sadeghnia H.R. Boswellia serrata has promising impact on glutamate and quinolinic acid-induced toxicity on oligodendroglia cells: in vitro study. Acta Pol. Pharm. 2017;74(6):1803\u20131811."}, {"Citation": "Lu C.W., Lin T.Y., Wang S.J. 11-Keto-\u03b2-Boswellic Acid Attenuates Glutamate Release and Kainic Acid-Induced Excitotoxicity in the Rat Hippocampus. Planta Med. 2020;86(6):434\u2013441.", "ArticleIdList": ["32097973"]}, {"Citation": "Sharma A., Kaur G. Tinospora cordifolia as a potential neuroregenerative candidate against glutamate induced excitotoxicity: an in vitro perspective. BMC Complement. Altern. Med. 2018;18(1):268.", "ArticleIdList": ["PMC6167833", "30285727"]}, {"Citation": "Sharma A., Kalotra S., Bajaj P., Singh H., Kaur G. Butanol extract of Tinospora cordifolia ameliorates cognitive deficits associated with glutamate-induced excitotoxicity: A mechanistic study using hippocampal neurons. Neuromolecular Med. 2020;22(1):81\u201399.", "ArticleIdList": ["31606849"]}, {"Citation": "Prasansuklab A., Tencomnao T. Acanthus ebracteatus leaf extract provides neuronal cell protection against oxidative stress injury induced by glutamate. BMC Complement. Altern. Med. 2018;18(1):278.", "ArticleIdList": ["PMC6192065", "30326896"]}, {"Citation": "Sukprasansap M., Chanvorachote P., Tencomnao T. Cleistocalyx nervosum var. paniala berry fruit protects neurotoxicity against endoplasmic reticulum stress-induced apoptosis. Food Chem. Toxicol. 2017;103:279\u2013288.", "ArticleIdList": ["28315776"]}, {"Citation": "Prasansuklab A., Meemon K., Sobhon P., Tencomnao T. Ethanolic extract of Streblus asper leaves protects against glutamate-induced toxicity in HT22 hippocampal neuronal cells and extends lifespan of Caenorhabditis elegans. BMC Complement. Altern. Med. 2017;17(1):551.", "ArticleIdList": ["PMC5745612", "29282044"]}, {"Citation": "Brimson J.M., Prasanth M.I., Plaingam W., Tencomnao T. Bacopa monnieri (L.) wettst. Extract protects against glutamate toxicity and increases the longevity of Caenorhabditis elegans. J. Tradit. Complement. Med. 2020;10(5):460\u2013470.", "ArticleIdList": ["PMC7484969", "32953562"]}, {"Citation": "Zhao H., Ji Z.H., Liu C., Yu X.Y. Neuroprotective Mechanisms of 9-Hydroxy Epinootkatol Against Glutamate-Induced Neuronal Apoptosis in Primary Neuron Culture. J. Mol. Neurosci. 2015;56(4):808\u2013814.", "ArticleIdList": ["25854778"]}, {"Citation": "Chen H., Cao J., Zhu Z., Zhang G., Shan L., Yu P., Wang Y., Sun Y., Zhang Z. A Novel tetramethylpyrazine derivative protects against glutamate-induced cytotoxicity through PGC1\u03b1/Nrf2 and PI3K/Akt signaling pathways. Front. Neurosci. 2018;12(567)", "ArticleIdList": ["PMC6104130", "30158850"]}, {"Citation": "Pan R-Y., Ma J., Wu H-T., Liu Q-S., Qin X-Y., Cheng Y. Neuroprotective effects of a Coeloglossum viride var. Bracteatum extract in vitro and in vivo. Sci. Rep. 2017;7(1):9209.", "ArticleIdList": ["PMC5569100", "28835690"]}, {"Citation": "de Oliveira M.R., Duarte A.R., Chenet A.L., de Almeida F.J.S., Andrade C.M.B. Carnosic acid pretreatment attenuates mitochondrial dysfunction in SH-SY5Y cells in an experimental model of glutamate-induced excitotoxicity. Neurotox. Res. 2019;36(3):551\u2013562.", "ArticleIdList": ["31016690"]}, {"Citation": "Assis L.C., Straliotto M.R., Engel D., Hort M.A., Dutra R.C., de Bem A.F. \u03b2-Caryophyllene protects the C6 glioma cells against glutamate-induced excitotoxicity through the Nrf2 pathway. Neuroscience. 2014;279:220\u2013231.", "ArticleIdList": ["25194788"]}, {"Citation": "Ahmad A., Mishra R.K., Vyawahare A., Kumar A., Rehman M.U., Qamar W., Khan A.Q., Khan R. Thymoquinone (2-Isopropyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects. Saudi Pharm. J. 2019;27(8):1113\u20131126.", "ArticleIdList": ["PMC6921197", "31885471"]}, {"Citation": "Atta M.S., Almadaly E.A., El-Far A.H., Saleh R.M., Assar D.H., Al Jaouni S.K., Mousa S.A. Thymoquinone defeats diabetes-induced testicular damage in rats targeting antioxidant, inflammatory and aromatase expression. Int. J. Mol. Sci. 2017;18(5):919.", "ArticleIdList": ["PMC5454832", "28448463"]}, {"Citation": "Erboga M., Kanter M., Aktas C., Sener U., Fidanol Erboga Z., Bozdemir Donmez Y., Gurel A. Thymoquinone ameliorates cadmium-induced nephrotoxicity, apoptosis, and oxidative stress in rats is based on its anti-apoptotic and anti-oxidant properties. Biol. Trace Elem. Res. 2016;170(1):165\u2013172.", "ArticleIdList": ["26226832"]}, {"Citation": "Al Mamun A., Hashimoto M., Katakura M., Hossain S., Shido O. Neuroprotective effect of thymoquinone against glutamate-induced toxicity in SH-SY5Y cells. Curr. Top. Nutraceutical Res. 2015;13(3):143."}, {"Citation": "Fouad I.A., Sharaf N.M., Abdelghany R.M., El Sayed N.S.E.D. Neuromodulatory effect of thymoquinone in attenuating glutamate-mediated neurotoxicity targeting the amyloidogenic and apoptotic pathways. Front. Neurol. 2018;9(236)", "ArticleIdList": ["PMC5908889", "29706929"]}, {"Citation": "Bin Sayeed M.S., Asaduzzaman M., Morshed H., Hossain M.M., Kadir M.F., Rahman M.R. The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers. J. Ethnopharmacol. 2013;148(3):780\u2013786.", "ArticleIdList": ["23707331"]}, {"Citation": "Liu C., Zhao H., Ji Z-H., Yu X-Y. Neuroprotection of atractylenolide III from Atractylodis macrocephalae against glutamate-induced neuronal apoptosis via inhibiting caspase signaling pathway. Neurochem. Res. 2014;39(9):1753\u20131758.", "ArticleIdList": ["24958167"]}, {"Citation": "Rebai O., Belkhir M., Sanchez-Gomez M.V., Matute C., Fattouch S., Amri M. Differential molecular targets for neuroprotective effect of chlorogenic acid and its related compounds against glutamate induced excitotoxicity and oxidative stress in rat cortical neurons. Neurochem. Res. 2017;42(12):3559\u20133572.", "ArticleIdList": ["28948515"]}, {"Citation": "dos Santos Souza C., Grangeiro M.S., Pereira E.P.L., dos Santos C.C., da Silva A.B., Sampaio G.P., Figueiredo D.D.R., David J.M., David J.P., da Silva V.D.A. Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity. Neurotoxicology. 2018;65:85\u201397.", "ArticleIdList": ["29425760"]}, {"Citation": "Li Y., Li J., Li S., Li Y., Wang X., Liu B., Fu Q., Ma S. Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP/NLRP3 inflammasome activation in a manner dependent on AMPK. Toxicol. Appl. Pharmacol. 2015;286(1):53\u201363.", "ArticleIdList": ["25791922"]}, {"Citation": "Wang R., Li Y-B., Li Y-H., Xu Y., Wu H-l., Li X-J. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res. 2008;1210:84\u201391.", "ArticleIdList": ["18420184"]}, {"Citation": "Chang C-H., Chen H-X., Y\u00fc G., Peng C-C., Peng R.Y. Curcumin-protected PC12 cells against glutamate-induced oxidative toxicity. Food Technol. Biotechnol. 2014;52(4):468\u2013478.", "ArticleIdList": ["PMC5079148", "27904320"]}, {"Citation": "Pereira E.P.L., Braga-de-Souza S., Santos C.C., Santos L.O., Cerqueira M.D., Ribeiro P.R., Fernandez L.G., Silva V.D.A., Costa S.L. Amburana cearensis seed extracts protect PC-12 cells against toxicity induced by glutamate. Rev. Bras. Farmacogn. 2017;27(2):199\u2013205."}, {"Citation": "Kang S.Y., Lee K.Y., Park M.J., Kim Y.C., Markelonis G.J., Oh T.H., Kim Y.C. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol. Learn. Mem. 2003;79(1):11\u201318.", "ArticleIdList": ["12482674"]}, {"Citation": "Lee H.Y., Weon J.B., Ryu G., Yang W.S., Kim N.Y., Kim M.K., Ma C.J. Neuroprotective effect of Aronia melanocarpa extract against glutamate-induced oxidative stress in HT22 cells. BMC Complement. Altern. Med. 2017;17(1):207.", "ArticleIdList": ["PMC5387295", "28399910"]}, {"Citation": "Koo K.A., Kim S.H., Oh T.H., Kim Y.C. Acteoside and its aglycones protect primary cultures of rat cortical cells from glutamate-induced excitotoxicity. Life Sci. 2006;79(7):709\u2013716.", "ArticleIdList": ["16566948"]}, {"Citation": "Shivasharan B.D., Nagakannan P., Thippeswamy B.S., Veerapur V.P. Protective effect of Calendula officinalis L. flowers against monosodium glutamate induced oxidative stress and excitotoxic brain damage in rats. Indian J. Clin. Biochem. 2013;28(3):292\u2013298.", "ArticleIdList": ["PMC3689330", "24426226"]}, {"Citation": "Hosseini A., Sadeghnia H.R., Rajabian A. Protective effects of peel and seed extracts of Citrus aurantium on glutamate-induced cytotoxicity in PC12 cell line. Folia Neuropathol. 2016;54(3):265\u2013272.", "ArticleIdList": ["27764519"]}, {"Citation": "Sadeghnia H.R., Rajabian A., Ghorbani A., Moradzadeh M., Hosseini A. Effects of standardized extract of Ferula gummosa root on glutamate-induced neurotoxicity. Folia Neuropathol. 2017;55(4):340\u2013346.", "ArticleIdList": ["29363909"]}, {"Citation": "Weon J.B., Yang H.J., Lee B., Yun B-R., Ahn J.H., Lee H.Y., Ma C.J. Neuroprotective activity of the methanolic extract of Lonicera japonica in glutamate-injured primary rat cortical cells. Pharmacogn. Mag. 2011;7(28):284.", "ArticleIdList": ["PMC3261061", "22262930"]}, {"Citation": "Sucontphunt A., De-Eknamkul W., Nimmannit U., Dan Dimitrijevich S., Gracy R.W. Protection of HT22 neuronal cells against glutamate toxicity mediated by the antioxidant activity of Pueraria candollei var. mirifica extracts. J. Nat. Med. 2011;65(1):1\u20138.", "ArticleIdList": ["20658198"]}, {"Citation": "Brimson J.M., Brimson S.J., Brimson C.A., Rakkhitawatthana V., Tencomnao T. Rhinacanthus nasutus extracts prevent glutamate and amyloid-\u03b2 neurotoxicity in HT-22 mouse hippocampal cells: Possible active compounds include lupeol, stigmasterol and \u03b2-sitosterol. Int. J. Mol. Sci. 2012;13(4):5074\u20135097.", "ArticleIdList": ["PMC3344267", "22606031"]}, {"Citation": "Chen X., Liu J., Gu X., Ding F. Salidroside attenuates glutamate-induced apoptotic cell death in primary cultured hippocampal neurons of rats. Brain Res. 2008;1238:189\u2013198.", "ArticleIdList": ["18680733"]}, {"Citation": "Song J.H., Kim S-Y., Hwang G.S., Kim Y-S., Kim H.Y., Kang K.S. Sanguiin H-11 from Sanguisorbae radix protects HT22 murine hippocampal cells against glutamate-induced death. Bioorg. Med. Chem. Lett. 2019;29(2):252\u2013256.", "ArticleIdList": ["30497912"]}, {"Citation": "Jeong G-S., Li B., Lee D-S., Byun E., An R-B., Pae H-O., Chung H-T., Youn K-H., Kim Y-C. Lavandulyl flavanones from Sophora flavescens protect mouse hippocampal cells against glutamate-induced neurotoxicity via the induction of heme oxygenase-1. Biol. Pharm. Bull. 2008;31(10):1964\u20131967.", "ArticleIdList": ["18827364"]}, {"Citation": "Jang J-Y., Kim H-N., Kim Y-R., Hong J-W., Choi Y-W., Choi Y-H., Shin H-K., Choi B-T. Hexane extract from Uncaria sinensis exhibits anti-apoptotic properties against glutamate-induced neurotoxicity in primary cultured cortical neurons. Int. J. Mol. Med. 2012;30(6):1465\u20131472.", "ArticleIdList": ["22992887"]}, {"Citation": "Ahn S.M., Kim H.N., Kim Y.R., Oh E.Y., Choi Y.W., Shin H.K., Choi B.T. Neuroprotective effect of 1-methoxyoctadecan-1-ol from Uncaria sinensis on glutamate-induced hippocampal neuronal cell death. J. Ethnopharmacol. 2014;155(1):293\u2013299.", "ArticleIdList": ["24877848"]}, {"Citation": "Shimada Y., Goto H., Itoh T., Sakakibara I., Kubo M., Sasaki H., Terasawa K. Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats. J. Pharm. Pharmacol. 1999;51(6):715\u2013722.", "ArticleIdList": ["10454049"]}, {"Citation": "Shimada Y., Goto H., Kogure T., Shibahara N., Sakakibara I., Sasaki H., Terasawa K. Protective effect of phenolic compounds isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death. Am. J. Chin. Med. 2001;29(01):173\u2013180.", "ArticleIdList": ["11321476"]}, {"Citation": "Kataria H., Wadhwa R., Kaul S.C., Kaur G. Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One. 2012;7(5):e37080.", "ArticleIdList": ["PMC3351387", "22606332"]}, {"Citation": "Dar N.J., Satti N.K., Dutt P., Hamid A., Ahmad M. Attenuation of glutamate-induced excitotoxicity by withanolide-A in neuron-like cells: Role for PI3K/Akt/MAPK signaling pathway. Mol. Neurobiol. 2018;55(4):2725\u20132739.", "ArticleIdList": ["28447311"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "3"}, {"Year": "2021", "Month": "3", "Day": "10"}, {"Year": "2021", "Month": "4", "Day": "3"}, {"Year": "2021", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "13", "Hour": "5", "Minute": "30"}, {"Year": "2022", "Month": "3", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33845746", "PMC8762182", "10.2174/1570159X19666210412095251", "CN-EPUB-115257"]}}], "PubmedBookArticle": []}